Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
The Biden administration has announced a new vaccine strategy to control the growing monkeypox outbreak in the U.S.
-
The Biden administration announced that it will drop the requirement for travelers coming to the United States by air to test negative for COVID-19 before departure.
-
The White House is announcing its plan to roll out COVID vaccines for children under 5. If the FDA and CDC give the go ahead next week, the administration says it has 10 million doses ready to go.
-
While President Biden honored the 19 children and two teachers killed in the massacre at Robb Elementary School, residents want to know why the police were slow to respond to the shooting.
-
The Centers for Disease Control and Prevention will require travelers to mask up in airports, planes, buses, trains and at transit hubs until May 3. That mandate had been set to expire next week.
-
The FDA curbed the use of two out of three monoclonal antibody treatments. Studies show they're highly unlikely to work against the omicron variant, which is overwhelming hospitals.
-
Antibody-based drug Evusheld protects immune-suppressed people against COVID-19 for up to six months. The drug is hard to get, and some hospitals are selecting patients by lottery.
-
The CDC says the change is "motivated by science" showing that it's not necessary to isolate for 10 days. During a surge of a more transmissible variant, is it a good idea to revise the guideline?
-
Pfizer's analysis shows that the drug is good at keeping people at high risk of COVID-19 from getting worse. The pill is called Paxlovid.
-
The first case of the omicron COVID variant has been identified in the U.S. Health officials found it in a traveler who had returned from South Africa just before Thanksgiving.